Fig. 4From: Semi-quantitative FDG parameters predict survival in multiple myeloma patients without autologous stem cell transplantationSurvival curves in the non-ASCT cohort according to the newly developed risk staging system. Compared with survival curves based on conventional R-ISS staging, the new proposed system combined FDG parameters with R-ISS staging and provided better prognostic discrimination. Staging that incorporated SUVmax (A) or SUVmean (B) effectively differentiated survival outcomes across stages. Staging systems that incorporated MTV (C), TLG (D), or FL (E) also yielded significantly improved risk stratificationBack to article page